DAY ONE BIOPHARMACEUTICALS I (DAWN) Stock Analyst Earnings Estimates
NASDAQ:DAWN - Nasdaq - US23954D1090 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 36.94% | N/A 79.37% | N/A 42.57% | N/A 30.26% | N/A 42.39% | N/A 15.57% | N/A 9.37% | N/A 16.18% | ||||||
| EBITDA YoY % growth | -14.91M | -13.76M 7.71% | -72.72M -428.49% | -146.85M -101.94% | -206.028M -40.30% | N/A 1.51% | N/A 30.87% | N/A 70.39% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -14.91M | -13.78M 7.58% | -72.74M -427.87% | -146.91M -101.97% | -206.064M -40.27% | N/A 3.64% | N/A 36.32% | N/A 67.51% | N/A 315.91% | N/A 120.49% | N/A 64.79% | N/A 27.56% | N/A 39.42% | N/A 23.67% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.17 36.64% | -2.38 -9.68% | N/A 68.80% | N/A -46.72% | N/A 78.33% | N/A 431.63% | N/A 143.00% | N/A 28.69% | N/A 18.61% | N/A 15.92% | N/A 13.79% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.37 42.31% | -0.32 55.23% | -0.28 -454.88% | -0.23 38.25% | -0.15 59.94% |
| Revenue Q2Q % growth | 28.345M | 33.813M | 40.476M 394.09% | 47.83M 138.32% | 53.911M 90.20% |
| EBITDA Q2Q % growth | -40.8M 31.41% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -42.148M 29.18% | -29.421M 55.93% | -26.039M 77.32% | -21.882M -173.84% | -21.131M 49.86% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.37 31.48% | -0.42 | 0.05 | 11.53% |
| Q2 2024 Q2Q % growth | -0.05 91.80% | -0.77 | 0.72 | 93.47% |
| Q1 2024 Q2Q % growth | -0.72 -22.03% | -0.68 | -0.04 | -6.41% |
| Q4 2023 Q2Q % growth | -0.64 -14.29% | -0.59 | -0.05 | -7.56% |
| Q3 2023 Q2Q % growth | -0.54 -1.89% | -0.61 | 0.07 | 12.11% |
| Q2 2023 Q2Q % growth | -0.61 -1.67% | -0.62 | 0.01 | 1.98% |
| Q1 2023 Q2Q % growth | -0.59 -22.92% | -0.60 | 0.01 | 2.33% |
| Q4 2022 Q2Q % growth | -0.56 -55.56% | -0.58 | 0.02 | 3.12% |
| Q3 2022 Q2Q % growth | -0.53 -60.61% | -0.54 | 0.01 | 2.70% |
| Q2 2022 Q2Q % growth | -0.60 88.10% | -0.50 | -0.10 | -20.66% |
| Q1 2022 Q2Q % growth | -0.48 | -0.39 | -0.09 | -22.23% |
| Q4 2021 Q2Q % growth | -0.36 | -0.36 | 0.00 | 1.28% |
| Q3 2021 Q2Q % growth | -0.33 | -0.29 | -0.04 | -15.44% |
| Q2 2021 Q2Q % growth | -5.04 | -0.32 | -4.72 | -1,468.63% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 20.07M | 24.016M | -3.946M | -16.43% |
| Q2 2024 Q2Q % growth | 8.192M | 1.042M | 7.15M | 686.18% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 20.69% | 20.69% | 12.92% | 12.92% |
| Revenue | 2.37% | 2.3% | 1.67% | 6.96% |